Caroline Lauren Sokol, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sensory Receptor Cells | 10 | 2024 | 513 | 3.930 |
Why?
|
Hypersensitivity | 8 | 2024 | 1171 | 2.760 |
Why?
|
Allergens | 10 | 2024 | 1432 | 2.460 |
Why?
|
Neuroimmunomodulation | 3 | 2024 | 182 | 1.810 |
Why?
|
Neuropeptides | 3 | 2024 | 944 | 1.160 |
Why?
|
Basophils | 4 | 2010 | 407 | 1.110 |
Why?
|
Dendritic Cells | 6 | 2024 | 2747 | 0.910 |
Why?
|
Immunity, Innate | 7 | 2022 | 3066 | 0.880 |
Why?
|
Pruritus | 2 | 2024 | 380 | 0.880 |
Why?
|
Interleukin-3 | 1 | 2024 | 425 | 0.860 |
Why?
|
Ganglia, Spinal | 4 | 2023 | 526 | 0.830 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2024 | 347 | 0.810 |
Why?
|
Helminths | 1 | 2022 | 39 | 0.810 |
Why?
|
Th2 Cells | 5 | 2023 | 1060 | 0.760 |
Why?
|
Sunburn | 1 | 2021 | 156 | 0.700 |
Why?
|
Skin | 5 | 2024 | 4484 | 0.670 |
Why?
|
Substance P | 1 | 2020 | 335 | 0.660 |
Why?
|
Receptors, CCR7 | 2 | 2020 | 107 | 0.660 |
Why?
|
Receptors, CCR8 | 1 | 2018 | 28 | 0.630 |
Why?
|
Enteric Nervous System | 1 | 2020 | 212 | 0.550 |
Why?
|
Food Hypersensitivity | 1 | 2024 | 729 | 0.530 |
Why?
|
Lymph Nodes | 4 | 2020 | 3465 | 0.440 |
Why?
|
Chemokines | 2 | 2015 | 959 | 0.440 |
Why?
|
Papain | 2 | 2009 | 65 | 0.390 |
Why?
|
Wound Healing | 1 | 2021 | 2805 | 0.340 |
Why?
|
Immunity | 3 | 2021 | 996 | 0.310 |
Why?
|
Inflammation | 5 | 2023 | 10774 | 0.290 |
Why?
|
Proteomics | 1 | 2021 | 3848 | 0.280 |
Why?
|
Animals | 23 | 2024 | 168475 | 0.270 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 964 | 0.250 |
Why?
|
STAT5 Transcription Factor | 1 | 2024 | 265 | 0.220 |
Why?
|
Receptors, Neuropeptide | 1 | 2024 | 106 | 0.220 |
Why?
|
Silymarin | 1 | 2023 | 46 | 0.210 |
Why?
|
Cell Movement | 5 | 2020 | 5205 | 0.210 |
Why?
|
Mice | 15 | 2024 | 81539 | 0.200 |
Why?
|
Receptors, Pattern Recognition | 1 | 2022 | 83 | 0.190 |
Why?
|
Epidermis | 1 | 2024 | 528 | 0.190 |
Why?
|
Caspase 8 | 1 | 2021 | 190 | 0.190 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.190 |
Why?
|
Leukotriene C4 | 1 | 2021 | 79 | 0.180 |
Why?
|
Th1 Cells | 2 | 2020 | 1036 | 0.180 |
Why?
|
Receptors, Leukotriene | 1 | 2021 | 95 | 0.180 |
Why?
|
Steel | 1 | 2020 | 27 | 0.170 |
Why?
|
Cytokines | 3 | 2024 | 7396 | 0.170 |
Why?
|
Tissue Culture Techniques | 1 | 2021 | 290 | 0.170 |
Why?
|
Decision Trees | 1 | 2021 | 504 | 0.160 |
Why?
|
Chemokine CCL8 | 1 | 2018 | 17 | 0.160 |
Why?
|
Nociceptors | 1 | 2023 | 461 | 0.160 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22174 | 0.150 |
Why?
|
Interleukin-18 | 1 | 2020 | 250 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 95 | 0.150 |
Why?
|
Immune System | 2 | 2021 | 796 | 0.150 |
Why?
|
Adaptive Immunity | 2 | 2020 | 726 | 0.150 |
Why?
|
Disease Susceptibility | 1 | 2024 | 1787 | 0.140 |
Why?
|
Uncertainty | 1 | 2022 | 754 | 0.140 |
Why?
|
Mast Cells | 1 | 2024 | 1392 | 0.140 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 483 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2021 | 1175 | 0.130 |
Why?
|
Immunization | 1 | 2020 | 1227 | 0.130 |
Why?
|
Inflammasomes | 1 | 2020 | 526 | 0.130 |
Why?
|
Lymphocyte Activation | 4 | 2018 | 5485 | 0.120 |
Why?
|
Fibrosis | 1 | 2021 | 2049 | 0.110 |
Why?
|
Signal Transduction | 4 | 2024 | 23447 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2021 | 731 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 588 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2021 | 14417 | 0.100 |
Why?
|
Cells, Cultured | 3 | 2018 | 18966 | 0.100 |
Why?
|
Stromal Cells | 1 | 2018 | 1330 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18255 | 0.100 |
Why?
|
Antigens, CD | 3 | 2018 | 4001 | 0.100 |
Why?
|
Humans | 17 | 2024 | 761596 | 0.090 |
Why?
|
Receptors, Chemokine | 1 | 2014 | 652 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2021 | 0.090 |
Why?
|
Mice, Inbred BALB C | 5 | 2020 | 6214 | 0.080 |
Why?
|
Antigens, Helminth | 1 | 2009 | 68 | 0.080 |
Why?
|
Antibodies, Antinuclear | 2 | 2001 | 343 | 0.080 |
Why?
|
Cell Differentiation | 5 | 2010 | 11530 | 0.080 |
Why?
|
Respiratory Mucosa | 1 | 2011 | 439 | 0.070 |
Why?
|
Immune System Diseases | 1 | 2010 | 256 | 0.070 |
Why?
|
Immunologic Memory | 2 | 2014 | 1359 | 0.070 |
Why?
|
Interleukin-4 | 2 | 2009 | 1149 | 0.070 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2011 | 587 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2451 | 0.070 |
Why?
|
Homeostasis | 2 | 2015 | 3323 | 0.070 |
Why?
|
Adoptive Transfer | 1 | 2009 | 819 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5767 | 0.070 |
Why?
|
Antibody Formation | 1 | 2010 | 1395 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 957 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2009 | 1435 | 0.060 |
Why?
|
Lymphoid Tissue | 2 | 2018 | 445 | 0.060 |
Why?
|
Male | 6 | 2024 | 360846 | 0.050 |
Why?
|
Female | 7 | 2024 | 392705 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4576 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2417 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4125 | 0.050 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2001 | 239 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 624 | 0.040 |
Why?
|
Leukocytes | 1 | 2008 | 2026 | 0.040 |
Why?
|
Trans-Activators | 1 | 2009 | 2856 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2009 | 5870 | 0.040 |
Why?
|
Chemokine CCL19 | 1 | 2018 | 35 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2009 | 4369 | 0.040 |
Why?
|
Dendritic Cells, Follicular | 1 | 2018 | 50 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5882 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8181 | 0.030 |
Why?
|
Gene Expression | 1 | 2009 | 7581 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 1999 | 4758 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5799 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2001 | 3701 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2273 | 0.030 |
Why?
|
Career Choice | 1 | 2018 | 756 | 0.020 |
Why?
|
Rats | 1 | 2008 | 23741 | 0.020 |
Why?
|
Mice, Inbred MRL lpr | 2 | 2001 | 153 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5722 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2011 | 1248 | 0.020 |
Why?
|
Pseudomonas Infections | 1 | 2011 | 622 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1999 | 2155 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15601 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9319 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1802 | 0.020 |
Why?
|
DNA | 1 | 1999 | 7213 | 0.020 |
Why?
|
Immunotherapy | 1 | 2020 | 4652 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16990 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2011 | 1277 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 2001 | 9542 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1999 | 10194 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2001 | 216 | 0.010 |
Why?
|
Lymphocytosis | 1 | 2001 | 121 | 0.010 |
Why?
|
Nephritis | 1 | 2001 | 145 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2001 | 750 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2001 | 915 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2001 | 778 | 0.010 |
Why?
|
Antibody-Producing Cells | 1 | 1999 | 140 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2001 | 1749 | 0.010 |
Why?
|
Sialoglycoproteins | 1 | 1999 | 315 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1999 | 357 | 0.010 |
Why?
|
CD40 Ligand | 1 | 1999 | 522 | 0.010 |
Why?
|
Species Specificity | 1 | 2001 | 2414 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2001 | 1869 | 0.010 |
Why?
|
Ligands | 1 | 2001 | 3272 | 0.010 |
Why?
|
Autoimmunity | 1 | 1999 | 1356 | 0.010 |
Why?
|
Phosphorylation | 1 | 1999 | 8321 | 0.000 |
Why?
|